Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report

Purpose: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. Observation: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment...

Full description

Bibliographic Details
Main Authors: Sinsucha Boontantrapiwat, Duangnate Rojanaporn, Weerawan Chokthaweesak, Naris Kitnarong
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993622004534
_version_ 1811311134870863872
author Sinsucha Boontantrapiwat
Duangnate Rojanaporn
Weerawan Chokthaweesak
Naris Kitnarong
author_facet Sinsucha Boontantrapiwat
Duangnate Rojanaporn
Weerawan Chokthaweesak
Naris Kitnarong
author_sort Sinsucha Boontantrapiwat
collection DOAJ
description Purpose: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. Observation: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment with favipiravir, intravenous dexamethasone, and ceftriaxone. An ocular examination of her right eye revealed periorbital tenderness, exophthalmos, and corneal haze. The ultrasonography showed a subretinal abscess. Her right eye lost light perception vision and underwent enucleation. Microbiologic evaluation of the enucleated right eye was negative for organisms. Conclusions and importance: Patents with COVID-19 may develop severe ocular involvement after COVID-19 due to a generalized reduction in immunity. Comorbidities and intensive care unit treatments can predispose COVID-19 patients to endogenous panophthalmitis.
first_indexed 2024-04-13T10:12:24Z
format Article
id doaj.art-d8c658c063644afabdf29135eae4858c
institution Directory Open Access Journal
issn 2451-9936
language English
last_indexed 2024-04-13T10:12:24Z
publishDate 2022-12-01
publisher Elsevier
record_format Article
series American Journal of Ophthalmology Case Reports
spelling doaj.art-d8c658c063644afabdf29135eae4858c2022-12-22T02:50:52ZengElsevierAmerican Journal of Ophthalmology Case Reports2451-99362022-12-0128101707Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case reportSinsucha Boontantrapiwat0Duangnate Rojanaporn1Weerawan Chokthaweesak2Naris Kitnarong3Krathumbaen Hospital, ThailandDepartment of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, ThailandDepartment of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, ThailandDepartment of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; Corresponding author. Department of Ophthalmology Faculty of Medicine Siriraj Hospital, Mahidol University 2 Prannok Road, Bangkoknoi, Bangkok, 10700, Thailand.Purpose: To report a case of endogenous panophthalmitis in a patient with COVID-19 during treatment in an Intensive Care Unit. Observation: A 64‐year‐old woman with COVID-19 and Salmonella septicemia presented with decreased visual acuity, ocular pain, and proptosis in her right eye after treatment with favipiravir, intravenous dexamethasone, and ceftriaxone. An ocular examination of her right eye revealed periorbital tenderness, exophthalmos, and corneal haze. The ultrasonography showed a subretinal abscess. Her right eye lost light perception vision and underwent enucleation. Microbiologic evaluation of the enucleated right eye was negative for organisms. Conclusions and importance: Patents with COVID-19 may develop severe ocular involvement after COVID-19 due to a generalized reduction in immunity. Comorbidities and intensive care unit treatments can predispose COVID-19 patients to endogenous panophthalmitis.http://www.sciencedirect.com/science/article/pii/S2451993622004534COVID-19Endogenous panophthalmitisEnucleationEndophthalmitisOcular manifestationSalmonella septicemia
spellingShingle Sinsucha Boontantrapiwat
Duangnate Rojanaporn
Weerawan Chokthaweesak
Naris Kitnarong
Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report
American Journal of Ophthalmology Case Reports
COVID-19
Endogenous panophthalmitis
Enucleation
Endophthalmitis
Ocular manifestation
Salmonella septicemia
title Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report
title_full Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report
title_fullStr Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report
title_full_unstemmed Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report
title_short Endogenous panophthalmitis in a patient with COVID-19 during hospitalization in an intensive care unit: A case report
title_sort endogenous panophthalmitis in a patient with covid 19 during hospitalization in an intensive care unit a case report
topic COVID-19
Endogenous panophthalmitis
Enucleation
Endophthalmitis
Ocular manifestation
Salmonella septicemia
url http://www.sciencedirect.com/science/article/pii/S2451993622004534
work_keys_str_mv AT sinsuchaboontantrapiwat endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport
AT duangnaterojanaporn endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport
AT weerawanchokthaweesak endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport
AT nariskitnarong endogenouspanophthalmitisinapatientwithcovid19duringhospitalizationinanintensivecareunitacasereport